how many units of 2.5 mg semaglutide A new study conducted by leading researchers across the United States suggests GLP-1s could have a much greater impact beyond obesity. Link in bio Switching from compounded semaglutide to

These signs could actually point to gastroparesis

Norepinephrine appears to be the neurotransmitter of arousal and it is for this reason that medications for depression and ADHD often target both dopamine and norepinephrine in an attempt to restore them to normal levels

Protein-rich regimens have taken off after millions of Americans found that stocking their pantries with supposedly "heart-healthy" snacks such as granola bars and fruit juice failed to improve wellness

What Medicares Temporary Program Covering GLP-1s for Obesity Means for Beneficiaries The Centers for Medicare & Medicaid Services (CMS) has released a memo fleshing out the design of a short-term program providing Medicare coverage of GLP-1s for obesity in 2026 ahead of a multi-year demonstration program beginning in 2027